- American Express reported earnings per share (EPS) of $3.64 for the first quarter, surpassing the estimated $3.48.
- The company set aside $1.2 billion as a provision for credit losses.
- American Express is maintaining its full-year revenue growth guidance of 8 to 10 percent.
- The full-year EPS forecast remains between $15.00 and $15.50, consistent with previous guidance.
- The company’s strong performance reflects the strength of its premium customer base.
- Analyst recommendations for American Express include 14 buy ratings, 17 hold ratings, and 3 sell ratings.
“`
A look at American Express Co Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores for American Express Co, the company’s long-term outlook appears promising. With a strong Growth score of 4, American Express Co shows potential for future expansion and development. This highlights the company’s ability to grow its business and capture new opportunities in the market. Additionally, the Resilience and Momentum scores of 3 each indicate that American Express Co has the capacity to withstand challenges and maintain a steady performance over time.
American Express Co also demonstrates a commitment to providing value and returns to its investors, as reflected in its Value and Dividend scores of 2 each. While these scores are not as high as the Growth score, they still show that the company is focused on delivering value to shareholders. Overall, American Express Co‘s balanced performance across the Smartkarma Smart Scores suggests a positive outlook for the company’s future prospects in the payment and travel industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
